BioSpecifics Technologies Corp. (BSTC)
-NasdaqGM 15.62 0.00(0.00%) 9:41AM EDT - Nasdaq Real Time Price
| Prev Close: | 15.62 |
|---|
| Open: | 15.55 |
|---|
| Bid: | 15.63 x 100 |
|---|
| Ask: | 15.93 x 100 |
|---|
| 1y Target Est: | 33.00 |
|---|
| Beta: | 1.28 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 15.55 - 15.62 |
|---|
| 52wk Range: | 12.52 - 21.99 |
|---|
| Volume: | 1,200 |
|---|
| Avg Vol (3m): | 15,535 |
|---|
| Market Cap: | 99.12M |
|---|
| P/E (ttm): | 30.63 |
|---|
| EPS (ttm): | 0.51 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, May 20)
- BIOSPECIFICS TECHNOLOGIES CORP FinancialsEDGAR Online Financials(Fri, May 17)
- Company News for May 13, 2013Zacks(Mon, May 13)
- BioSpecifics Technologies' Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 10)
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementEDGAR Online(Fri, May 10)
- BioSpecifics Technologies Corp. Reports First Quarter 2013 Financial ResultsPR Newswire(Fri, May 10)
- Q1 2013 Biospecifics Technologies Earnings Release - Time Not SuppliedCCBN(Fri, May 10)
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013PR Newswire(Fri, May 3)
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Thu, Apr 18)
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Wed, Apr 10)
- Positive Data on BSTC's XiaflexZacks(Mon, Apr 1)
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Wed, Mar 27)
- BioSpecifics Technologies Corp. Announces Positive Top-line Data from XIAFLEX® Phase IIa Study for Frozen ShoulderPR Newswire(Tue, Mar 26)
- BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-K, Annual ReportEDGAR Online(Fri, Mar 15)
Key Statistics
| Forward P/E (1 yr): | 22.00 |
|---|
| P/S (ttm): | 7.91 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.07 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | 1.47 |
|---|
Business Summary
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase for various clinical indications primarily in the United States.
View More 
0.69%